Comparative efficacy of different IVF stimulation protocols in women with adenomyosis undergoing fresh embryo transfer: a systematic review and network meta-analysis

In: Archives of Gynecology and Obstetrics · 2026 · doi:10.1007/s00404-026-08557-2 · W7208746173
article OA: gold CC0
⚙ AI-generated summary by qwen3.7-flash, 2026-09-09 ⓘ

This network meta-analysis found that the ultra-long GnRH agonist protocol yielded higher implantation rates than antagonist or short protocols in women with adenomyosis undergoing fresh embryo transfer, while focal disease showed lower miscarriage risk than diffuse disease.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by qwen3.7-flash, 2026-09-08 · read from full text ⓘ

This network meta-analysis evaluated the comparative efficacy of various ovarian stimulation protocols for women with adenomyosis undergoing fresh embryo transfer. The review included seven retrospective studies and found that the ultra-long GnRH agonist protocol yielded significantly higher implantation rates compared to antagonist and short protocols, although clinical pregnancy and live birth outcomes did not differ significantly. Subtype analysis revealed that while focal and diffuse adenomyosis had comparable pregnancy rates, focal disease was associated with a lower miscarriage risk, despite the overall evidence being derived from non-randomized data. This paper is centrally about adenomyosis — specifically assessing how different IVF stimulation strategies impact reproductive outcomes in patients with this condition.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Abstract Introduction Adenomyosis is associated with reduced IVF success, yet the optimal ovarian stimulation strategy remains unclear. Although prolonged GnRH agonist suppression has been widely used, its benefit in fresh embryo transfer cycles is inconsistent, and potential differences between focal and diffuse adenomyosis are poorly defined. This network meta-analysis compared reproductive outcomes across commonly used stimulation protocols in women with adenomyosis undergoing fresh embryo transfer, with additional analysis according to disease subtype. Objective This network meta-analysis evaluates the effectiveness of commonly used stimulation protocols in women with adenomyosis undergoing fresh embryo transfer and examines whether outcomes differ between focal and diffuse disease. Methods We systematically searched PubMed, Scopus, and Google Scholar from inception to November 2025 for randomized trials and cohort studies comparing ovarian stimulation protocols (ultra-long GnRH agonist, long GnRH agonist, GnRH antagonist, and short GnRH agonist) in women with adenomyosis undergoing fresh embryo transfer. Only studies with ultrasound- or MRI-confirmed adenomyosis and extractable fresh-cycle outcomes were included. Implantation, clinical pregnancy, miscarriage, and live birth were analyzed. A frequentist random-effects network meta-analysis was performed using risk ratios and 95% confidence intervals, with SUCRA values used to rank protocol efficacy. Risk of bias was assessed using the Cochrane tool and ROBINS-I, and certainty of evidence was evaluated through CINeMA. Results Seven retrospective studies were included. The ultra-long GnRH agonist protocol achieved the highest implantation rate and was significantly superior to the antagonist (RR 0.62; 95% CI 0.35–0.995) and short protocols (RR 0.53; 95% CI 0.31–0.83). No significant differences were observed for clinical pregnancy, miscarriage, or live birth, although Surface Under the Cumulative Ranking Curve (SUCRA) rankings consistently favoured the ultra-long regimen. In an exploratory subtype analysis, clinical pregnancy and live birth were comparable between focal and diffuse adenomyosis, whereas focal disease was associated with a lower miscarriage risk (RR 0.66; 95% CI 0.51–0.85). Conclusions The ultra-long GnRH agonist protocol appears to offer the most favorable reproductive outcomes for women with adenomyosis undergoing fresh embryo transfer, particularly for implantation and live birth probability. Focal adenomyosis is associated with lower miscarriage risk compared with diffuse disease, despite similar pregnancy and live birth rates. These findings support ultra-long down-regulation and routine subtype assessment, although confirmation in prospective trials is needed.
Full text 5,499 characters · extracted from oa-html · 5 sections · click to expand

Abstract

Introduction Adenomyosis is associated with reduced IVF success, yet the optimal ovarian stimulation strategy remains unclear. Although prolonged GnRH agonist suppression has been widely used, its benefit in fresh embryo transfer cycles is inconsistent, and potential differences between focal and diffuse adenomyosis are poorly defined. This network meta-analysis compared reproductive outcomes across commonly used stimulation protocols in women with adenomyosis undergoing fresh embryo transfer, with additional analysis according to disease subtype.

Objective

This network meta-analysis evaluates the effectiveness of commonly used stimulation protocols in women with adenomyosis undergoing fresh embryo transfer and examines whether outcomes differ between focal and diffuse disease.

Methods

We systematically searched PubMed, Scopus, and Google Scholar from inception to November 2025 for randomized trials and cohort studies comparing ovarian stimulation protocols (ultra-long GnRH agonist, long GnRH agonist, GnRH antagonist, and short GnRH agonist) in women with adenomyosis undergoing fresh embryo transfer. Only studies with ultrasound- or MRI-confirmed adenomyosis and extractable fresh-cycle outcomes were included. Implantation, clinical pregnancy, miscarriage, and live birth were analyzed. A frequentist random-effects network meta-analysis was performed using risk ratios and 95% confidence intervals, with SUCRA values used to rank protocol efficacy. Risk of bias was assessed using the Cochrane tool and ROBINS-I, and certainty of evidence was evaluated through CINeMA.

Results

Seven retrospective studies were included. The ultra-long GnRH agonist protocol achieved the highest implantation rate and was significantly superior to the antagonist (RR 0.62; 95% CI 0.35–0.995) and short protocols (RR 0.53; 95% CI 0.31–0.83). No significant differences were observed for clinical pregnancy, miscarriage, or live birth, although Surface Under the Cumulative Ranking Curve (SUCRA) rankings consistently favoured the ultra-long regimen. In an exploratory subtype analysis, clinical pregnancy and live birth were comparable between focal and diffuse adenomyosis, whereas focal disease was associated with a lower miscarriage risk (RR 0.66; 95% CI 0.51–0.85).

Conclusions

The ultra-long GnRH agonist protocol appears to offer the most favorable reproductive outcomes for women with adenomyosis undergoing fresh embryo transfer, particularly for implantation and live birth probability. Focal adenomyosis is associated with lower miscarriage risk compared with diffuse disease, despite similar pregnancy and live birth rates. These findings support ultra-long down-regulation and routine subtype assessment, although confirmation in prospective trials is needed. Abbreviations - 2D/3D US: - Two-dimensional/three-dimensional ultrasound - CINeMA: - Confidence in network meta-analysis - CI: - Confidence interval - GnRH-a: - Gonadotropin-releasing hormone agonist - GnRH: - Gonadotropin-releasing hormone - IVF: - In vitro fertilization - ICSI: - Intracytoplasmic sperm injection - MRI: - Magnetic resonance imaging - NMA: - Network meta-analysis - PRISMA: - Preferred reporting items for systematic reviews and meta-analyses - PROSPERO: - International prospective register of systematic reviews - ROBINS-I: - Risk of bias in non-randomized studies of interventions - RR: - Risk ratio - SUCRA: - Surface under the cumulative ranking curve Funding Open access funding provided by University of Padjadjaran. This publication charge is funded by Unpad through the Indonesian Endowment Fund for Education (LPDP) on behalf of the Indonesian Ministry of Higher Education, Science and Technology and managed under the EQUITY Program (Contract No. 4303/ B3/DT.03.08/2025 and 3927/UN6. RKT/HK.07.00/2025) Author information Authors and Affiliations Corresponding author Ethics declarations Conflict of interest The authors declare that there are no conflict of interest. Additional information Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Supplementary Information Below is the link to the electronic supplementary material. Rights and permissions Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. About this article Cite this article Syam, H.H., Bayuaji, H., Tjahyadi, D. et al. Comparative efficacy of different IVF stimulation protocols in women with adenomyosis undergoing fresh embryo transfer: a systematic review and network meta-analysis. Arch Gynecol Obstet (2026). https://doi.org/10.1007/s00404-026-08557-2 Received: Accepted: Published: DOI: https://doi.org/10.1007/s00404-026-08557-2

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-html ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2026) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

openalex
last seen: 2026-09-25T06:02:26.147369+00:00
License: CC0 · commercial use OK